Dynavax Technologies Corp (NAS:DVAX)
$ 13 -0.03 (-0.23%) Market Cap: 1.71 Bil Enterprise Value: 1.17 Bil PE Ratio: 100.23 PB Ratio: 2.51 GF Score: 70/100

Dynavax Technologies Corp at Cantor Fitzgerald Global Healthcare Conference (Virtual) Transcript

Sep 30, 2021 / 04:00PM GMT
Release Date Price: $19.21 (-1.18%)
John Walton
Cantor Fitzgerald - Analyst

Hi, all. Thank you for joining the Cantor 2021 Healthcare Conference. I'm happy to introduce Ryan Spencer, the CEO of Dynavax, who will walk you through his presentation. Take it away, Ryan.

Ryan Spencer
Dynavax Technologies Corporation - CEO

Hello, everyone. Thank you for joining us today. I'm Ryan Spencer, Chief Executive Officer of Dynavax. In this corporate overview, we will be making forward-looking statements that are subject to risks and uncertainties as identified on the slide and in our filings with the SEC, which provide details on our business and the associated investment risks, which we encourage you to review in detail.

I'm very excited to share with you today the Dynavax story and proud to represent a terrific team doing great things, which fortunately also represents, in our opinion, a great investment opportunity. Dynavax is building a leading vaccine company on the foundation of our significant experience and expertise in vaccine development and commercialization.

The ongoing

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot